ADHD and Pregnancy: Managing Symptoms Without Stimulants

Stopping your ADHD medication the moment you see a positive test can feel like the responsible thing to do. The research suggests that decision deserves more thought than a reflex.

ADHD shapes how your brain’s attention and planning systems work, and pregnancy doesn’t switch that wiring off. If anything, the months ahead ask more of those systems: appointments to track, decisions to make, and a body that’s changing week by week. Good care in pregnancy depends on precision, matching the level of treatment to how much your symptoms actually affect your safety and daily life.

The standard approach has been careful, case-by-case counseling: weigh the possible risks of medication against the risks of untreated symptoms, and decide together with your OB and prescriber. That approach rests on a fast-growing body of research. A 2017 cohort study of more than 1.4 million pregnancies, published in ACOG’s journal, found stimulants carried a small relative increase in preeclampsia, and the authors concluded that people with significant ADHD shouldn’t be counseled to stop treatment based on those findings alone. The approach is sound, and the evidence keeps getting stronger.

But most of that research focused on stimulants, and at Siggy we don’t believe “without stimulants” should ever mean “without a plan.”

This guide covers what’s known about non-stimulant and behavioral options in pregnancy, what the newest studies show, and where the gaps still are, because the right choice for you depends on weighing all of the evidence.

What This Page Covers

• Why Does ADHD Treatment Matter in Pregnancy?
• What Does the Research Say About Stimulants?
• Are Non-Stimulants a Safer Choice?
• How Do the Options Compare?
• What Non-Medication Treatments Help?
• How Can You Plan Ahead?
• How Siggy Fits In
• Start Your Anonymous Intake

Why Does ADHD Treatment Matter in Pregnancy?

More people are facing this decision than ever. A CDC analysis found the share of privately insured women aged 15 to 44 who filled an ADHD prescription rose from 0.9% in 2003 to 4.0% in 2015. The same report noted that nearly half of US pregnancies are unintended, so many people are exposed to medication before they know they’re pregnant.

That’s why “stop immediately” isn’t always the answer. For some people, untreated ADHD means missed appointments, unsafe driving, or trouble at work. For others, symptoms are mild enough that pausing medication with extra support works fine. If your ADHD was diagnosed later in life, our guide to ADHD in women and late diagnosis may help you see how symptoms show up for you.

What Does the Research Say About Stimulants?

Even if you’re hoping to avoid stimulants, it helps to know what the data show, because they shape the comparison. A US-Nordic cohort study of birth defects found no increase in malformations with amphetamines and a small increase in heart defects with methylphenidate, a pooled relative risk of 1.28.

For child development, a 2024 US cohort of stimulant exposure including more than 4 million pregnancies found amphetamine and methylphenidate exposure in later pregnancy were not likely to meaningfully increase autism, ADHD, or other neurodevelopmental conditions in children.

The newest summary is a 2026 meta-analysis of 25 studies covering stimulants and atomoxetine. After adjusting for other factors, exposure was not linked to major birth defects, miscarriage, preterm birth, or neurodevelopmental conditions. Two signals remained: a modest heart-defect association with methylphenidate and a slightly higher rate of low Apgar scores at birth. The authors cautioned that these should not be read as proof of harm.

Are Non-Stimulants a Safer Choice?

A non-stimulant isn’t automatically the safer choice in pregnancy, and that’s the part many people don’t hear. Atomoxetine (Strattera), the most studied non-stimulant, has less pregnancy data than stimulants, and the findings are mixed.

Some results are reassuring. A 2025 Swedish cohort and meta-analysis found no increased risk of neurodevelopmental conditions in children exposed to methylphenidate, amphetamines, or atomoxetine. A 2024 meta-analysis found no rise in birth defects or miscarriage with methylphenidate or atomoxetine.

Other results call for caution. A 2025 Norwegian study of pregnant women with ADHD linked any ADHD medication use to higher odds of miscarriage, with the highest estimate for atomoxetine, an odds ratio of 2.34. The authors noted that filled prescriptions may not reflect what people actually took. A related Nordic cohort found ADHD medication may modestly increase preterm birth risk, especially atomoxetine early in pregnancy.

The large studies focus mainly on methylphenidate, amphetamines, and atomoxetine, so pregnancy data for other options are thinner. Our guide to non-stimulant ADHD medications explains how each one works outside of pregnancy.

How Do the Options Compare?

Based on the studies above, here’s how the main approaches line up:

Approach	What Studies Show	Main Caveat
Continue a stimulant	No adjusted rise in major birth defects in pooled data	Small preeclampsia and heart-defect signals
Switch to atomoxetine	No rise in birth defects or child neurodevelopmental conditions	Less data, one miscarriage signal
Pause medication, add CBT	CBT improved symptoms in a trial of medicated adults	Not tested in pregnancy specifically
Pause medication, no added support	No medication exposure	Symptoms may return and affect safety

ACOG’s 2023 perinatal treatment guideline focuses on depression, anxiety, bipolar disorder, and psychosis rather than ADHD. That means ADHD decisions lean on this broader research and on shared decision-making with your care team.

What Non-Medication Treatments Help?

Cognitive behavioral therapy built for adult ADHD has the best evidence among non-medication options. In a randomized CBT trial for adult ADHD, 67% of adults who received 12 individual CBT sessions responded on a clinician-rated ADHD scale, compared with 33% in a relaxation and education group, and gains held at 12 months. Participants were already taking medication, so CBT worked as an add-on, which is useful whether you continue medication or pause it.

Practical supports can lower the load on your attention system too:

• One shared calendar for prenatal appointments, with reminders set days ahead
• A written list for each appointment so nothing gets lost in the moment
• Breaking big tasks, like preparing for the baby, into small steps with dates
• Asking a partner or friend to share specific tasks, not just “help”

How Can You Plan Ahead?

The best time to make this plan is before conception, or as early as possible after a positive test. Questions to bring to your OB and prescriber:

• How much do my symptoms affect driving, work, and safety right now?
• What are the options if I continue, switch, or pause medication?
• If I pause, what support will I have, and when do we check in?
• What’s the plan after delivery, when sleep loss can make symptoms harder?

Pregnancy and the postpartum period can also bring depression or anxiety. If you notice persistent low mood, panic, or thoughts of harming yourself or your baby, call 911 or call or text 988 right away. Our guide to antidepressants in pregnancy covers those medication decisions.

How Siggy Fits In

Siggy starts with a free, anonymous intake. No name, email, or account is needed. You can share your ADHD history, current medications, and pregnancy plans at your own pace. The intake is preclinical and does not diagnose you on its own.

A licensed prescriber reviews your answers before any plan is approved, considering more than one possible explanation for your symptoms. Siggy’s prescribers treat the full range of mental health conditions, and you get a downloadable summary to share with your OB so your care stays connected.

Siggy’s AI also provides therapy between visits, including CBT-based approaches, and what you share helps your care team adjust the plan as your pregnancy progresses.

This article is for education and is not a substitute for advice from your own OB or prescriber. It reflects sources available as of November 2026.

Start Your Anonymous Intake

Managing ADHD in pregnancy isn’t a choice between medication and doing nothing. Recent studies are broadly reassuring about stimulants, non-stimulants like atomoxetine have less data and at least one caution flag, and CBT can help whether or not you take medication. The best plan is one you make early, with your OB and prescriber, based on how ADHD affects your daily life. If you’re weighing medication types in general, our comparison of stimulant and non-stimulant ADHD medications is a good next read.

You don’t have to plan this alone. Start your anonymous intake with Siggy. It’s free, no name or email is required, and a real clinician reviews everything before any treatment is recommended.